UK markets closed

Lexicon Pharmaceuticals, Inc. (LXRX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.7000-0.0700 (-3.95%)
As of 12:14PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts5555
Avg. Estimate-0.19-0.19-0.76-0.69
Low estimate-0.21-0.23-0.87-0.75
High estimate-0.14-0.15-0.62-0.61
Year ago EPS-0.22-0.21-0.79-0.76
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts5555
Avg. Estimate2.83M7.83M24.11M83.69M
Low estimate1.8M3.5M14M52.1M
High estimate3.4M17.06M40.13M103.09M
Year ago salesN/A162k1.2M24.11M
Sales growth (year/est)N/A4,733.30%1,902.50%247.10%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-0.17-0.21-0.22-0.2
Actual EPS-0.22-0.21-0.2-0.2
Difference-0.0500.020
Surprise %-29.40%0.00%9.10%0.00%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.19-0.19-0.76-0.69
7 days ago-0.19-0.19-0.76-0.69
30 days ago-0.18-0.17-0.71-0.66
60 days ago-0.18-0.17-0.71-0.66
90 days ago-0.21-0.19-0.78-0.64
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days2231
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesLXRXIndustrySector(s)S&P 500
Current qtr.13.60%N/AN/AN/A
Next qtr.9.50%N/AN/AN/A
Current year3.80%N/AN/AN/A
Next year9.20%N/AN/AN/A
Next 5 years (per annum)54.70%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A